Relative to the current CGF Annuity sales rate of ~4bnA$/year, 640mA$/year of new reinsurance from MS&AD is no small deal. Margins on this business will be conceivably lower, but the average duration is significantly longer than the one of the existing Annuity book. Makes sense to diversify away from A$-denominated annuities, while these are penalised by the negative yield differential vis-a-vis US$.
- Forums
- ASX - By Stock
- Ann: Challenger expands strategic relationship with MS&AD
Relative to the current CGF Annuity sales rate of ~4bnA$/year,...
Featured News
Add CGF (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.26 |
Change
0.050(0.81%) |
Mkt cap ! $4.314B |
Open | High | Low | Value | Volume |
$6.33 | $6.34 | $6.23 | $717.6K | 114.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 4019 | $6.26 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.27 | 6642 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 3150 | 6.250 |
15 | 7730 | 6.240 |
10 | 4720 | 6.230 |
10 | 6134 | 6.220 |
8 | 17842 | 6.210 |
Price($) | Vol. | No. |
---|---|---|
6.260 | 188 | 3 |
6.270 | 1409 | 7 |
6.280 | 10712 | 7 |
6.290 | 4981 | 6 |
6.300 | 17914 | 8 |
Last trade - 11.24am 15/11/2024 (20 minute delay) ? |
Featured News
CGF (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online